Commencez
AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1

AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1

Pas de trades
Voir sur les super-graphiques
Vue d'ensembleFinancesActualitésIdéesMindsSaisonniersObligations

Obligations

Voici la liste des obligations d'entreprise de AbbVie, Inc. Shs Cert Deposito Arg Repr 0.1 . Les investisseurs optent souvent pour les obligations d'une société en raison de leur stabilité accrue en période de volatilité du marché. Étudiez les prix, les rendements et d'autres statistiques et trouvez un investissement fiable.
Symbole
YTM %
Volume
Prix %
Coupon %
Date d'échéance
Montant en suspens
Valeur nominale
Montant min de la dénomination
Émetteur
AACT4218883Allergan Funding SCS 4.75% 15-MAR-2045
7,00%26 K76,04%4,750%2045-03-1553,51 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
AACT3910526Actavis, Inc. 4.625% 01-OCT-2042
6,67%171 K79,41%4,625%2042-10-0167,49 M USD1 000,00 USD2 000,00 USDActavis, Inc.
AACT4176286Allergan Funding SCS 4.85% 15-JUN-2044
6,53%24 K82,04%4,850%2044-06-1565,23 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
XS190919331Allergan Funding SCS 2.625% 15-NOV-2028
6,24%090,21%2,625%2028-11-1572,11 M EUR1 000,00 EUR100 000,00 EURAllergan Funding SCS
ABBV4911706AbbVie Inc. 3.2% 21-NOV-2029
5,49%26 K90,47%3,200%2029-11-2162,52 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759196AbbVie Inc. 5.5% 15-MAR-2064
5,37%9,72 M102,10%5,500%2064-03-151,5 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
AACT4218882Allergan Funding SCS 4.55% 15-MAR-2035
5,30%22 K94,50%4,550%2035-03-15107,65 M USD1 000,00 USD2 000,00 USDAllergan Funding SCS
ABBV5759195AbbVie Inc. 5.4% 15-MAR-2054
5,29%27,39 M101,59%5,400%2054-03-153 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068387AbbVie Inc. 4.25% 21-NOV-2049
5,27%15,99 M86,13%4,250%2049-11-215,75 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV6009613AbbVie Inc. 5.6% 15-MAR-2055
5,27%7,91 M104,87%5,600%2055-03-15750 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAW9AbbVie Inc. 4.45% 14-MAY-2046
5,26%089,91%4,450%2046-05-142 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4693583AbbVie Inc. 4.875% 14-NOV-2048
5,25%776 K94,95%4,875%2048-11-141,75 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
4ABBAbbVie Inc. 4.7% 14-MAY-2045
5,25%093,33%4,700%2045-05-142,7 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068390AbbVie Inc. 4.75% 15-MAR-2045
5,20%1,45 M94,48%4,750%2045-03-15827,09 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068389AbbVie Inc. 4.85% 15-JUN-2044
5,19%315 K95,97%4,850%2044-06-151,01 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759204AbbVie Inc. 5.35% 15-MAR-2044
5,18%4,16 M101,98%5,350%2044-03-15750 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4036937AbbVie Inc. 4.4% 06-NOV-2042
5,10%791 K92,03%4,400%2042-11-062,6 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068388AbbVie Inc. 4.625% 01-OCT-2042
5,09%670 K94,77%4,625%2042-10-01389,22 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5068386AbbVie Inc. 4.05% 21-NOV-2039
4,93%5,46 M91,11%4,050%2039-11-214 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAV1AbbVie Inc. 4.3% 14-MAY-2036
4,65%097,07%4,300%2036-05-141 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAR0AbbVie Inc. 4.5% 14-MAY-2035
4,60%099,23%4,500%2035-05-142,5 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV6009165AbbVie Inc. 5.2% 15-MAR-2035
4,58%76 K104,71%5,200%2035-03-151 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5082874AbbVie Inc. 4.55% 15-MAR-2035
4,55%1,39 M100,02%4,550%2035-03-151,68 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5759203AbbVie Inc. 5.05% 15-MAR-2034
4,48%4,72 M103,93%5,050%2034-03-153 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
XXS162262122Allergan Funding SCS 2.125% 01-JUN-2029
4,42%092,48%2,125%2029-06-0136,46 M EUR1 000,00 EUR100 000,00 EURAllergan Funding SCS
ABBV5759202AbbVie Inc. 4.95% 15-MAR-2031
4,13%5 M103,91%4,950%2031-03-152 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
US287YAY5AbbVie Inc. 3.2% 14-MAY-2026
4,09%099,53%3,200%2026-05-142 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV6009612AbbVie Inc. 4.875% 15-MAR-2030
3,97%184 K103,61%4,875%2030-03-151 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5084327AbbVie Inc. 3.2% 21-NOV-2029
3,96%4,83 M97,14%3,200%2029-11-215,44 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5758814AbbVie Inc. 4.8% 15-MAR-2029
3,92%1,73 M102,79%4,800%2029-03-152,5 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5758813AbbVie Inc. 4.8% 15-MAR-2027
3,88%13,1 M101,25%4,800%2027-03-152,25 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4693581AbbVie Inc. 4.25% 14-NOV-2028
3,84%3,63 M101,16%4,250%2028-11-141,75 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV6009611AbbVie Inc. 4.65% 15-MAR-2028
3,82%4,83 M101,89%4,650%2028-03-151,25 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5084339AbbVie Inc. 2.95% 21-NOV-2026
3,79%5,62 M99,12%2,950%2026-11-213,99 B USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4998675AbbVie Inc. 4.75% 15-MAR-2045
3,16%0126,76%4,750%2045-03-155 K USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV5006799AbbVie Inc. 4.85% 15-JUN-2044
3,13%0128,71%4,850%2044-06-15100 K USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV4911718AbbVie Inc. 4.25% 21-NOV-2049
3,13%0121,31%4,250%2049-11-214,95 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
4ABGAbbVie Inc. 1.25% 18-NOV-2031
2,78%091,57%1,250%2031-11-18650 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
XS212591491AbbVie Inc. 2.125% 01-JUN-2029
2,61%098,36%2,125%2029-06-01506,09 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
ABBV5006798AbbVie Inc. 4.55% 15-MAR-2035
2,57%0123,74%4,550%2035-03-151 K USD1 000,00 USD2 000,00 USDAbbVie, Inc.
XS212591483AbbVie Inc. 2.625% 15-NOV-2028
2,45%0100,53%2,625%2028-11-15427,79 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
XS152090781AbbVie Inc. 2.125% 17-NOV-2028
2,41%099,17%2,125%2028-11-17750 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
4ABEAbbVie Inc. 0.75% 18-NOV-2027
2,28%096,94%0,750%2027-11-18750 M EUR1 000,00 EUR100 000,00 EURAbbVie, Inc.
ABBV4911704AbbVie Inc. 2.95% 21-NOV-2026
−5,92%0111,17%2,950%2026-11-219,24 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.
ABBV3926786AbbVie Inc. 4.4% 06-NOV-2042
———4,400%2042-11-061,1 M USD1 000,00 USD2 000,00 USDAbbVie, Inc.